Short QT syndrome
Gene: KCNJ2
Moderate evidence for autosomal dominant short QT syndrome 1 by ClinGen /gene curation expert panel (PMID: 34557911). 6 patients from 5 families with unique variants, including at least 2 probands with a de-novo variant. Classified as moderate evidence due to the absence of segregation or case-control data.
Gain of function mechanism reported. Experimental evidence demonstrated these variants lead to gain-of-function of the late repolarizing, KCNJ2-encoded Ik1 current in the heart, and abbreviation of the action potential duration.Created: 11 Oct 2021, 2:45 a.m. | Last Modified: 11 Oct 2021, 2:45 a.m.
Panel Version: 0.1
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Phenotypes
Short QT syndrome 1
Publications
Mode of pathogenicity
Other
Variants in this GENE are reported as part of current diagnostic practice
Gene: kcnj2 has been classified as Green List (High Evidence).
Phenotypes for gene: KCNJ2 were changed from to Short QT syndrome
Publications for gene: KCNJ2 were set to
Mode of pathogenicity for gene: KCNJ2 was changed from to Other
Mode of inheritance for gene: KCNJ2 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
gene: KCNJ2 was added gene: KCNJ2 was added to Short QT syndrome_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services Mode of inheritance for gene: KCNJ2 was set to Unknown